
DenovAI Biotech
DenovAI Biotech leverages AI for de novo protein design, focusing on novel therapeutics and diagnostics.
About
DenovAI Biotech designs bespoke proteins from scratch using artificial intelligence and computational molecular biophysics. Their core offerings include developing next-generation therapeutics like high-affinity antibodies and small protein/peptide biologics, as well as diagnostic reporters. They aim to transform human health by creating foundational technology platforms for de novo protein design.
Listed competitors
Also in this space
AI-driven digital twin of embryo development for cell-based therapies.
Shares Life Sciences, Therapeutics
Clinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.
Shares Life Sciences, Therapeutics
AI-powered platform for developing lipid nanoparticles for oligonucleotide therapies.
Shares Life Sciences, Therapeutics
AI-powered patient-centric drug simulations to accelerate and de-risk drug development.
Shares Life Sciences, Computational Biology
AI-driven platform for protein-level disease mapping and drug discovery.
Shares Life Sciences, Drug Discovery
Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.
Shares Life Sciences, Biotech
Key facts
- Website
- denovai.com
- Headquarters
- Rehovot, Israel
- Founded
- 2023
- Employees
- 11
- Business model
- B2B
Tech stack
Detected on denovai.com, last scanned 23 Oct 2026. Run your own scan
- Email provider
- Microsoft 365
DenovAI Biotech scores 8. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is DenovAI Biotech trustworthy and reputable?
StartupHub's Data Trust & Reputation score for DenovAI Biotech is 87 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How many employees does DenovAI Biotech have?
DenovAI Biotech has approximately 11 people on record.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for DenovAI Biotech


